Ömer Azal

728 total citations
38 papers, 412 citations indexed

About

Ömer Azal is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Ömer Azal has authored 38 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 7 papers in Reproductive Medicine. Recurrent topics in Ömer Azal's work include Hormonal and reproductive studies (7 papers), Retinal Diseases and Treatments (4 papers) and Ovarian function and disorders (4 papers). Ömer Azal is often cited by papers focused on Hormonal and reproductive studies (7 papers), Retinal Diseases and Treatments (4 papers) and Ovarian function and disorders (4 papers). Ömer Azal collaborates with scholars based in Türkiye, Serbia and Rwanda. Ömer Azal's co-authors include Abdullah Taşlıpınar, Alper Sönmez, Aydoğan Aydoğdu, Cengiz Açıkel, Süleyman Ceylan, Türker Türker, Erol Bolu, Mustafa Kutlu, Serkan Tapan and Mine Yavuz Taşlıpınar and has published in prestigious journals such as Journal of Periodontology, Clinical Endocrinology and Food Control.

In The Last Decade

Ömer Azal

37 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ömer Azal Türkiye 12 147 64 60 58 45 38 412
Leszek Markuszewski Poland 14 91 0.6× 49 0.8× 15 0.3× 71 1.2× 36 0.8× 72 500
Seong Bin Hong South Korea 13 135 0.9× 89 1.4× 23 0.4× 74 1.3× 9 0.2× 39 416
Abie Ekangaki Australia 9 106 0.7× 20 0.3× 43 0.7× 54 0.9× 9 0.2× 12 423
Mukadder Serter Türkiye 12 31 0.2× 152 2.4× 19 0.3× 56 1.0× 91 2.0× 29 620
Tsuyoshi Okura Japan 13 182 1.2× 150 2.3× 15 0.3× 65 1.1× 18 0.4× 37 594
Maria Jelinic Australia 21 72 0.5× 137 2.1× 17 0.3× 74 1.3× 78 1.7× 37 881
Do‐Houn Kim United States 6 117 0.8× 150 2.3× 50 0.8× 45 0.8× 40 0.9× 9 667
Miaomiao Peng China 10 125 0.9× 64 1.0× 51 0.8× 62 1.1× 13 0.3× 23 428
Xiaoyi Zhang China 10 183 1.2× 49 0.8× 13 0.2× 54 0.9× 11 0.2× 20 632
Ahmed Mahgoub United States 9 82 0.6× 73 1.1× 81 1.4× 84 1.4× 9 0.2× 34 394

Countries citing papers authored by Ömer Azal

Since Specialization
Citations

This map shows the geographic impact of Ömer Azal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ömer Azal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ömer Azal more than expected).

Fields of papers citing papers by Ömer Azal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ömer Azal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ömer Azal. The network helps show where Ömer Azal may publish in the future.

Co-authorship network of co-authors of Ömer Azal

This figure shows the co-authorship network connecting the top 25 collaborators of Ömer Azal. A scholar is included among the top collaborators of Ömer Azal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ömer Azal. Ömer Azal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Demirci, İbrahim, et al.. (2017). A Life-Long Disease: Diabetes. International Journal of Medical Research & Health Sciences. 6(8). 156–166.
2.
Haymana, Cem, Alper Sönmez, Aydoğan Aydoğdu, et al.. (2017). Wpływ testosteronowej terapii zastępczej na stężenia witaminy D i FGF-23 w hipogonadyzmie wrodzonym. Endokrynologia Polska. 68(3). 311–616. 5 indexed citations
3.
Haymana, Cem, et al.. (2017). Assessment of a low ankle brachial index in young males with congenital hypogonadism. 1–1. 1 indexed citations
4.
Aydoğdu, Aydoğan, Cem Haymana, Onur Erdem, et al.. (2015). Trace Element Levels in Congenital Hypogonadotrophic Hypogonadism. Biological Trace Element Research. 171(1). 26–32. 2 indexed citations
5.
Arslan, Nuri, Semra İnce, Salih Deveci, et al.. (2015). Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma. Nuclear Medicine Communications. 36(10). 1021–1025. 13 indexed citations
6.
Aydoğdu, Aydoğan, İlker Taşçı, Ferhat Denız, et al.. (2014). Effects of valsartan treatment on serum ghrelin level and left ventricular mass index in patients with untreated primary hypertension. Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology. 14(3). 234–238. 4 indexed citations
7.
Aydoğdu, Aydoğan, Tolga Ege, İlker Taşçı, et al.. (2014). Increased Calcaneal Spur Frequency in Patients with Obesity and Type-2 Diabetes Mellitus. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi. 60(1). 12–16. 5 indexed citations
9.
Aydoğdu, Aydoğan, İlker Taşçı, Serkan Tapan, et al.. (2012). High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome. Gynecological Endocrinology. 28(9). 722–725. 25 indexed citations
10.
Denız, Ferhat, et al.. (2012). Mutations in the AVPR2, AVP-NPII, and AQP2 genes in Turkish patients with diabetes insipidus. Endocrine. 42(3). 664–669. 16 indexed citations
11.
Aydoğdu, Aydoğan, İlker Taşçı, Serkan Tapan, et al.. (2012). Increase in subcutaneous adipose tissue and fat free mass in women with polycystic ovary syndrome is related to impaired insulin sensitivity. Gynecological Endocrinology. 29(2). 152–155. 12 indexed citations
12.
Taşlıpınar, Abdullah, Mine Yavuz Taşlıpınar, Ömer Azal, et al.. (2009). Epicardial adipose tissue thickness and serum visfatin levels in patients with new diagnosed prediabetes and type 2 diabetes mellitus. 1 indexed citations
13.
Ermiş, Necip, Ferhat Denız, Alper Kepez, et al.. (2009). Heart rate variability of young men with idiopathic hypogonadotropic hypogonadism. Autonomic Neuroscience. 152(1-2). 84–87. 11 indexed citations
14.
Ceylan, Süleyman, et al.. (2008). Complementary and alternative medicine use among Turkish diabetes patients. Complementary Therapies in Medicine. 17(2). 78–83. 68 indexed citations
15.
Erdoğan, Murat Faik, et al.. (2006). Multiple endocrine neoplasia 2B presenting with pseudo-Hirschsprung's disease.. PubMed. 98(5). 783–6. 11 indexed citations
16.
Azal, Ömer, et al.. (2002). Effects of aminoguanidine and tolrestat on the development of ocular and renal structural changes in experimental diabetic rats. Diabetes Obesity and Metabolism. 4(1). 75–79. 9 indexed citations
17.
Dokucu, Ali İhsan, Yusuf Yağmur, Abdurrahman Önen, et al.. (2000). Colon injuries in children. Journal of Pediatric Surgery. 35(12). 1799–1804. 18 indexed citations
18.
Dokucu, Ali İhsan, Maria Emília de Souza Fabre, Selçuk Otçu, et al.. (2000). Zenker's Diverticulum in Childhood: A New Case. European Journal of Pediatric Surgery. 10(3). 191–193. 7 indexed citations
19.
Azal, Ömer. (1998). Visual Evoked Potentials in Diabetic Patients. DergiPark (Istanbul University). 5 indexed citations
20.
Günhan, Meral, et al.. (1996). Gingival Langerhans' Cells in Type I Diabetes Mellitus. Journal of Periodontology. 67(1). 37–40. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026